Michael Wood | LifeSci Advisors |
Chaim Lebovits | President and Chief Executive Officer |
Stacy Lindborg | Co-Chief Executive Officer |
Alla Patlis | Interim Chief Financial Officer |
David Setboun | Chief Operating Officer |
Jason McCarthy | Maxim Group |
David Bautz | Zacks Small-Cap Research |
Greetings, and welcome to the Brainstorm Cell Therapeutics Fourth Quarter 2022 Earnings Call. At this time, all participants are in a listen-only mode.
As a reminder, this call is being recorded.
And I will now like to introduce your host for today's call, Michael Wood of LifeSci Advisors. Mr.